Eva Pisa
Vermogen: 217 784 $ op 31-05-2026
Vermogen: 217 784 $ op 31-05-2026
Eva Pisa is currently a Member of the Supervisory Board at QIAGEN NV since 2022.
Formerly, Dr. Pisa was Chief Executive Officer at Cepheid AB from 2001 to 2007 and SVP-Roche Centralized & POC Solutions at Roche Diagnostics International AG from 2007 to 2020.
Education includes a doctorate from Karolinska Institutet and an MBA from Heriot-Watt University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 28-02-2026 | 5.952 ( 0% ) | 217 784 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| QIAGEN N.V. | Directeur/Bestuurslid | 23-06-2022 |
| Bedrijven | Functie | Einde |
|---|---|---|
Roche Diagnostics International AG
Roche Diagnostics International AG Medical SpecialtiesHealth Technology Manufactures and supplies diagnostics systems | Corporate Officer/Principal | 01-01-2020 |
Cepheid AB
Cepheid AB Medical/Nursing ServicesHealth Services Develops and provides molecular diagnostic testing | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
QIAGEN NV
QIAGEN NV Medical SpecialtiesHealth Technology Manufactures and distributes sample and assay technology products for pre-analytical sample preparations | Health Technology |
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Heriot-Watt University
Heriot-Watt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cepheid AB
Cepheid AB Medical/Nursing ServicesHealth Services Develops and provides molecular diagnostic testing | Health Services |
Roche Diagnostics International AG
Roche Diagnostics International AG Medical SpecialtiesHealth Technology Manufactures and supplies diagnostics systems | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau